FDA inspection
RenovoRx, Inc.: FDA inspection ending Apr 4, 2022
FDA inspection 1166306 · Voluntary Action Indicated (VAI) · Mountain View, CA
Key facts
| Inspection ID | 1166306 |
|---|---|
| Firm | RenovoRx, Inc. |
| FEI number | 3011279674 |
| Address | 4546 El Camino Real Ste B1 |
| City | Mountain View |
| State | CA |
| ZIP | 94040 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Apr 4, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data